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Available online 5 January 2013Abstract The developmental pathway that gives rise to mature adipocytes involves commitment and terminal
differentiation. Our previous findings indicate that BMP4 (bone morphogenetic protein 4) induces nearly complete
commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage and knockdown of lysyl oxidase (Lox) disrupts
this commitment process. Here, we found that an epithelial–mesenchymal transition (EMT)-like response is required for
adipocyte lineage commitment and that Lox is indispensable for this process. When C3H10T1/2 cells were treated with BMP4,
Vim and Cdh2 showed up-regulated expression while Cdh1 and Ocln were down-regulated along with enhanced cell migration,
which are EMT-like responses. Silencing of Lox in BMP4-treated C3H10T1/2 cells induced a mesenchymal–epithelial transition
(MET)-like response associated with the repression of mesenchymal markers, induction of epithelial markers and decreased cell
migration. Importantly, blocking the EMT-like response by knocking down Cdh2 or over-expression of Cdh1 impairs adipocyte
lineage commitment. EMT is regulated by distinct transcription factors such as Snai1, Snai2 and Twist. In this study, we also
found that only Twist was down-regulated after Lox silencing in C3H10T1/2 cells treated with BMP4. This study provides new
insights into adipocyte lineage commitment.
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279Role of EMT-like response on adipocyte lineage commitmentIntroduction
Obesity is linked with many metabolic disorders including
type 2 diabetes, cardiovascular diseases, Alzheimer's dis-
ease, and even certain cancers (Cornier et al., 2008; Craft,
2007; Hsu et al., 2007). Increases in both adipocyte number
and size are the fundamental processes of obesity. The
increase in adipocyte number is the result of commitment of
mesenchymal stem cells (MSCs) to preadipocytes (Yu et al.,
1997) and the mitotic clonal expansion of committed
preadipocytes (Tang et al., 2003) during the adipocyte
differentiation program. Since MSCs have the capacity to
commit to various lineages, e.g., adipocytes, osteocytes,
myocytes, and chondrocytes, it is critical for the study of
obesity to understand how they commit to the adipocytic
lineage. The commitment of stem cells to these different
lineages is triggered by many cues in the local tissue
microenvironment. Recently, it has been demonstrated
that treatment with BMP2/4 induces the commitment of
C3H10T1/2 mesenchymal stem cells to the adipocyte lineage
(Huang et al., 2009, 2011; Tang et al., 2004), and an
independent line of investigation also supports the role of
BMPs in the commitment of MSCs to the adipocyte lineage
(Bowers et al., 2006).
The epithelial–mesenchymal transition (EMT) is a biological
process that causes epithelial cells to lose their epithelial
phenotype and acquire properties ofmesenchymal cells. EMT is
characterized by loss of epithelial markers such as Cdh1 and
Ocln; the decrease in epithelial genes expression is
accompanied by increased expression of mesenchymal
genes (Vim, Cdh2, etc.) (Furuse et al., 1993; Hay, 1995;
Ikenouchi et al., 2003; Kalluri and Neilson, 2003; Rastaldi,
2006). These alterations are usually accompanied by an
increase of cell motility. The epithelial–mesenchymal
transition plays crucial roles in the differentiation of multiple
tissues and organs (Dedhar et al., 2006). Recent studies have
demonstrated that BMP4 induces an EMT (Huber et al., 2005;
Satoh et al., 2007; Theriault et al., 2007). We therefore
speculated that an EMT also occurs during adipocyte lineage
commitment.
Lox, a copper-containing amine oxidase, has been shown to
be induced by BMP2/4 during adipocyte lineage commitment.
Moreover, knockdown of Lox expression prevents adipocyte
commitment and differentiation of MEFs (mouse embryonic
fibroblasts) as well as C3H10T1/2 stem cells (Huang et al.,
2009). Lox is also known to be selectively expressed and to be
implicated in hypoxia-induced EMT (Erler et al., 2006; Higgins
et al., 2007; Schietke et al., 2010). These findings raised the
question of whether BMP4 could regulate Lox expression and
thus induce the EMT during adipocyte lineage commitment. In
this study, we found that BMP4 induced an EMT-like response
during adipocyte lineage commitment and the EMT-like
response is required for adipocyte lineage commitment. Our
further studies showed that Lox contributes to the BMP4-
induced EMT-like response during this commitment process.
EMT can be transcriptionally regulated by developmentally
important transcription factors including Snai1, Snai2, Twist,
and Zeb2 (Bolos et al., 2003; Comijn et al., 2001; Nawshad et
al., 2004; Yang et al., 2004). Our studies also demonstrated
that only Twist expression was correlated with LOX expression
and contributed to adipocyte lineage commitment.Materials and methods
Induction of adipocyte lineage commitment
and differentiation
To induce commitment, C3H10T1/2 stem cells were plated at
low density and cultured in DMEM containing 10% calf serum
and 20 ng/ml purified recombinant BMP4 (R & D Systems,
Minneapolis, MN, USA). To induce differentiation, 2-day
postconfluent cells were fed with DMEM containing 10% fetal
bovine serum (FBS), 1 μg/ml insulin (I), 1 μM dexamethasone
(D) and 0.5 mM 3-isobutyl-1-methylxanthine (M) for 2 days
and then with DMEM containing 10% FBS and 1 μg/ml insulin
for another 2 days, after which they were cultured in DMEM
with 10% FBS. On day 8 the cells were washed, fixed and
stained with Oil Red O as described (Tang et al., 2003).
Immunoblotting
Cells werewashedwith cold PBS (pH 7.4) and then scraped into
lysis buffer containing 50 mM Tris-HCl (pH 6.8), 2% SDS, 10%
glycerol, phosphatase inhibitors (10 mM Na3VO4, 10 mM NaF)
and protease inhibitor cocktail (Roche). The lysates were
heated at 100 °C for 10 min and clarified by centrifugation.
Equal amounts of protein were subjected to SDS/PAGE and
immunoblotted with specific primary antibodies. 422/aP2
antibody was a gift from Dr. Lane's laboratory. Snai2 antibody
was purchased from Abcam (Cambridge, UK). Lox, Twist and
Ocln antibodies were from Santa Cruz Biotechnology (Delaware
Avenue, CA, USA). Snai1 antibody was from Cell Signaling
Technology (Beverly, MA, USA). Cdh1, Cdh2 and Vim antibodies
were from BD Bioscience (San Diego, CA, USA) and β-actin
antibody was from Sigma-Aldrich (St. Louise, MO, USA).
Oil Red O staining
On day 8 after induction the cells werewashed three timeswith
PBS and then fixed for 10 min with 3.7% formaldehyde. Oil Red
O (0.5% in isopropanol) was diluted with water (3:2), filtered
through a 0.45 μm filter, and incubated with the fixed cells for
1 h at room temperature. After that, the cells were washed
with water and the stained fat droplets in the adipocytes were
visualized by light microscopy and photographed.
RNA interference
Stealth siRNA duplexes were designed and synthesized by
Invitrogen (Carlsbad, CA). The silencing effects of several
siRNA duplexes were screened and tested initially for their
ability to knock down expression of target genes by Western
blotting. The sequences for successful RNAi knockdown were:
5′-AAUAUUUGCAGUUGAAGAUCUUCCG-3′ for Snai1; 5′-UAUUC
CUUGUCACAGUACUUGCAGC-3′ for Snai2; 5′-GCGGAUGUCAGA
GACUAUGACCACA-3′ for Lox; 5′-AGGAAGUCGAUGUACCUGGCC
GCCA-3′ for Twist1; 5′-UUCACACGCAGGAUGGAAAUGUUGG-3′
for Cdh2; Stealth™ siRNA Negative Control Duplexes with a
similar GC content were used as control. C3H10T1/2 stem cells
were transfected at 30–50% confluence with siRNA duplexes
using Lipofectamine RNAi MAX (Invitrogen, Carlsbad, CA)
according to the manufacturer's instructions.
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C3H10T1/2 cells were plated on coverslips and treated as
described above; day 0 (two days postconfluence) cells were
washed three times with phosphate-buffered saline (PBS) and
fixed in 4% (w/v) formaldehyde for 10 min at room temper-
ature. Theywere then permeabilizedwith 0.1% Triton X-100 in
PBS for 10 min and blocked with 10% fetal bovine serum/PBS
for 2 h. The coverslips were incubated with anti-Cdh2 primary
antibody in the same buffer overnight (1:50, BD Bioscience)
and then with FITC-conjugated secondary antibodies for 1 h.
Nuclei were counterstained with DAPI. Images were captured
using a Leica confocal microscope (Leica TCS SP5, Germany).Figure 1 An EMT-like response occurs during adipocyte lineage
cultured with or without BMP4 at 20 ng/ml until postconfluence. (A)
visualized by fluorescence microscopy. (B) The cells were stained wi
visualized by fluorescence microscopy. (C) Expression of various EM
markers of EMT and Cdh1 and Ocln as epithelial phenotype marke
control. (D) Wounding assays were conducted on BMP4-treated or un
cells were treated with vehicle or BMP4 for 24 h after producing a
panels) and 24 h (right panels). (E) The percentage of the total are
assessed using Image J software. Bars represent the standard
(F) Comparison of relative numbers of C3H10T1/2 cells treated withScrape wound migration assay
C3H10T1/2 cells were labeled with the green fluorescent
protein (GFP). GFP was expressed in C3H10T1/2 cells using a
mouse stem cell virus (MSCV) retroviral system. Confluent cells
for assay were scraped using a sterilized 200 μl tip and non-
adherent cells were washed off with medium. The cells were
then treated with vehicle or BMP4 for 24 h. Cell migration was
observed and photographed using a fluorescence microscope.
Experiments were conducted three times independently. The
percentage of total area covered by the cells in each image was
calculated using the National Institutes of Health image analysis
software program Image J.commitment. C3H10T1/2 cells were plated at low density and
GFP-labeled C3H10T1/2 cells treated with or without BMP4 were
th anti-Cdh2 plus FITC-conjugated secondary antibodies (green),
T markers (Vim and Cdh2 protein as mesenchymal phenotype
rs) was assessed by immunoblotting. β-actin served as loading
treated C3H10T1/2 cells to evaluate their motility. GFP-labeled
1 mm wound. Images depict the wound space at time 0 h (left
a covered by C3H10T1/2 cells treated with vehicle or BMP4 was
deviation from three independent experiments. **Pb0.01.
vehicle or BMP4 as determined by cell counting.
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Cells were fixed with 1% formaldehyde for 10 min at room
temperature with swirling. Glycine was added to a final
concentration of 0.125 M and the incubation was continued for
an additional 5 min. The cells werewashed twicewith ice-cold
PBS, harvested by scraping, pelleted, and resuspended in 1 ml
of SDS lysis buffer (50 mM Tris-HCl, pH 8.0, 1% SDS, 10 mM
EDTA, and protease inhibitors). Samples were immuno-
precipitated using Lox antibodies (Abcam, Cambridge, MA) or
the nonspecific rabbit IgG control (Abcam, Cambridge, MA).
Immunoprecipitated samples were eluted and reverse cross-
linked by incubation overnight at 65 °C in elution buffer
(50 mM Tris-HCl, pH 8.0, 10 mM EDTA, 1% SDS). Genomic DNA
was then extracted with a PCR purification kit (Qiagen,
Valencia, CA). Purified DNA was subjected to quantitative
PCR amplification using the specific primer for the binding of
Lox in the Twist1 gene promoter (sense primer, 5′-TTGGA
GTTAGCGGACA-3′; antisense primer, 5′-AGGCTGGAGTTCATT
CT-3′).
Results
An EMT-like response occurs during adipocyte
lineage commitment
As previously reported, BMP4 induced the commitment of
C3H10T1/2 stem cells into cells that possess the character-
istics of preadipocytes (Huang et al., 2009, 2011; Tang et
al., 2004), which further differentiated into adipocytes. ThisFigure 2 Blocking the expression of Cdh2 inhibits BMP4-induced ad
in Cdh2-silenced C3H10T1/2 cells. C3H10T1/2 cells were plated at lo
negative control RNAi. After 24 h, they were cultured with or witho
expression of EMT markers was assessed by immunoblotting. (B) The
and subsequent differentiation was assessed by staining for cytopl
transfected with Cdh2 Stealth™ RNAi. After 24 h they were treate
differentiate using a standard adipocyte differentiation protocol. (
marker (422/aP2) was assessed by immunoblotting at day 6 after coestablished cell model was used in the following experiments to
unravel the mechanism involved in adipocyte lineage commit-
ment. Cell shape has been shown to play a role in adipocyte
lineage commitment and development (Huang et al., 2011;
Meyers et al., 2005; Treiser et al., 2010), and our previously
published data also showed that committed C3H10T1/2 cells
undergo a cell shape change from flattened morphology to
ovoid when reaching confluence (Fig. 1A) (Huang et al., 2011).
The cell shape change is accompanied by the induction of Cdh2
(Figs. 1A, B), which resembles an epithelial–mesenchymal
transition. This prompted us to investigate the involvement of
an EMT during adipocyte lineage commitment. We examined
VimandCdh2 protein asmesenchymalmarkers of EMT and Cdh1
and Ocln as epithelial markers in control cells and cells exposed
to BMP4. Expression of mesenchymal markers was increased
and expression of epithelial markers was decreased during
BMP4-induced adipocyte lineage commitment (Fig. 1C). A
wounding assay was also used to examine the motility of
BMP4-treated and control C3H10T1/2 cells. The effects of BMP4
on C3H10T1/2 cell migration were more obvious (**Pb0.01)
(Figs. 1D & E), whereas its effect on C3H10T1/2 cell pro-
liferation seemedmodest (Fig. 1F). These results demonstrated
that an EMT-like phenotype occurs during BMP4-induced
adipocyte lineage commitment.The EMT-like response is required for adipocyte
lineage commitment
We next explored whether the observed EMT-like response is a
consequence of or required for the adipocyte lineageipocyte lineage commitment. (A) Western blot for EMT markers
w density. They were transfected with Cdh2 Stealth™ RNAi and a
ut BMP4 until postconfluence; extracts were prepared and the
effect of knocking down Cdh2 on adipocyte lineage commitment
asmic triglyceride. C3H10T1/2 cells were plated as above and
d with or without BMP4 until postconfluence; then induced to
C) The effect of knocking down Cdh2 on an adipocyte-specific
cktail induction.
282 H.-Y. Huang et al.commitment. Loss of the epithelial adhesion protein Cdh1 and
gain of the mesenchymal marker Cdh2 are two hallmarks of an
EMT. It has been reported that ectopic expression of Cdh2 is
sufficient to cause an EMT in prostate cancer cells (Tanaka et
al., 2010). Other studies have shown that complete loss of Cdh1
protein by shRNA results in an EMT, and forced expression of
Cdh1 induces a switch from fibroblastic to epithelial morphol-
ogy (Onder et al., 2008; Sarrió et al., 2009). On the basis of
these studies, we knocked down Cdh2 or over-expressed Cdh1
to inhibit EMT-like process during adipocyte lineage commit-
ment. We first studied whether Cdh2 knockdown would blunt
adipocyte lineage commitment. For this we used a set of small
interfering RNAs. Cdh2 was significantly knocked down in both
BMP4-treated cells and control cells as confirmed by WesternFigure 3 Effect of Lox on the EMT-like response during adipocyte lin
EMT-like response. C3H10T1/2 cells were plated at 30% confluence an
they were cultured with BMP4 until postconfluence; extracts were pre
immunoblotting. (B) Inhibition of Lox down-regulates the expression of
control RNAi. After 24 h, they were treated with BMP4 until postconfl
and nuclei were counterstained with DAPI (blue). (C) Effect of Lox inh
Migration was analyzed by a scrape-wound migration assay at 0 h and
points. (D) Wound closure in (C) was measured using Image J softwar
experiments. **Pb0.01. (E) Depletion of Lox inhibits adipocyte differ
with Lox Stealth™ RNAi. After 24 h they were treated with BMP4 unt
adipocyte differentiation protocol. On day 6 they were stained with Oblotting (Figs. 2A & S2A). The basal expression levels of EMT
markers were slightly changed when the expression level of
Cdh2 was knocked down in control cells (Fig. S2A). The basal
expression level of adipocyte-specific 422/aP2 gene and the
accumulation of cytoplasmic fat droplets were prevented when
Cdh2 was knocked down in control C3H10T1/2 cells (Figs. S2B &
C). Knocking down of Cdh2 in BMP4-treated cells blocked the
BMP4-induced EMT-like response as assessed by mesenchymal
markers and epithelialmarkers. Meanwhile, the commitment of
C3H10T1/2 cells to the adipocyte lineage induced by BMP4 is
also blocked, as assessed byOil RedO staining and 422/aP2 gene
expression (Figs. 2B & C). The loss of Cdh1 expression is
another hallmark of an EMT. We therefore also tested
whether over-expression of Cdh1 could induce similar changes.eage commitment. (A) Depletion of Lox inhibits the BMP4-induced
d transfected with Lox Stealth™ RNAi or control RNAi. After 24 h,
pared and the expression of Lox and EMT markers was assessed by
Cdh2. C3H10T1/2 cells were transfectedwith Lox Stealth™ RNAi or
uence. Cdh2 protein was assessed by immunofluorescence (green)
ibition on cell migration. C3H10T1/2 cells were labeled with GFP.
24 h. The “wounded” areas were examined at the indicated time
e. Bars represent the standard deviation from three independent
entiation. C3H10T1/2 cells were plated as above and transfected
il postconfluence, then induced to differentiate using a standard
il Red O.
Figure 4 Twist expression is correlated with LOX expression. (A) Western blots for Snai1, Snai2 and Twist in control cells and
BMP4-treated cells. C3H10T1/2 stem cells were plated at 30% confluence and after 24 h they were treated with BMP4 until
postconfluence, at which time whole cell extracts were prepared for immunoblotting with antibodies as indicated. (B) Correlation of
the expression intensity of Lox and major EMT transcription factors. C3H10T1/2 cells were plated as above and transfected with Lox
Stealth™ RNAi and control RNAi. After 24 h they were treated with BMP4 until postconfluence, at which time whole cell extracts were
prepared for immunoblotting. (C) Binding of Lox to the Twist1 promoter was confirmed by ChIP. C3H10T1/2 cells were treated with or
without BMP4 until postconfluence. ChIP-qPCR was performed with anti-Lox antibody, and nonspecific rabbit IgG was used as
negative control. Data are normalized to the IgG controls.
283Role of EMT-like response on adipocyte lineage commitmentOver-expression of Cdh1 resulted in inhibition of both the
BMP4-induced EMT-like response and adipocyte lineage
commitment, which was similar to the inhibition of Cdh2
(Figs. S1A–1C). These findings suggested that the EMT-like
response is required for adipocyte lineage commitment.Lox contributes to the EMT-like response during
adipocyte lineage commitment
We have previously shown that BMP4 induces the expression of
Lox during adipocyte lineage commitment (Fig. 3A) (Huang etFigure 5 Twist is required for BMP4-induced EMT-like response a
EMT-like response during adipocyte lineage commitment. C3H10T1/2
Stealth™ RNAi. After 24 h they were cultured with or without BMP
expression of Twist and EMT markers was assessed by immunoblottin
terminal differentiation was assessed both by expression of 422/aP2al., 2011; Huang et al., 2009). Lox has also been shown to be
coupled to an EMT (Erler et al., 2006; Higgins et al., 2007;
Schietke et al., 2010; Sion and Figg, 2006; Taylor et al., 2011).
In light of the above results and those linking an EMT to
elevated Lox expression, we further examined the role of Lox
in mediating the EMT-like response during adipocyte lineage
commitment. Lox was significantly knocked down in BMP4-
treated cells and control cells as confirmed by Western
blotting (Figs. 3A & S2A). The basal expression levels of
mesenchymal markers and epithelial markers were slightly
changed when Lox was knocked down in control C3H10T1/2
cells (Fig. S2A). The basal adipogenesis was preventedwhen Loxnd adipocyte lineage commitment. (A) Twist is required for the
cells were plated at 30% confluence and transfected with Twist
4 until postconfluence, when extracts were prepared and the
g. Effect of knockdown of Twist on adipocyte commitment and
(B) and by staining of cytoplasmic triglyceride (C).
284 H.-Y. Huang et al.was knocked down in control C3H10T1/2 cells (Figs. S2B & C).
Inhibition of Lox in BMP4-treated cells abrogated the down-
regulation of Cdh1 and Ocln and up-regulation of Vim and Cdh2
induced by BMP4 which was a MET-like process (Fig. 3A).
Furthermore, immunofluorescence analysis showed attenuated
expression of Cdh2 in Lox-silenced cells (Fig. 3B). A wounding
assay was also used to examine cell motility after Lox knock-
down. Over a period of 24 h, the motility of Lox-silenced cells
decreased significantly when compared to negative control
cells (Figs. 3C & D). These results demonstrated that silencing
the expression of Lox inhibited the BMP4-induced EMT-like
response and triggered a MET-like process. The effect of Lox
on the EMT-like response coincided with its effect on BMP4-
induced adipocyte lineage commitment (Fig. 3E), further
indicating the adipogenic effect of the EMT-like process.Figure 6 Snai1 and Snai2 do not contribute to the acquisition
of adipocyte phenotype induced by BMP4. (A) Knockdown of
Snai1 and Snai2 expression in postconfluent cells was confirmed
by immunoblotting. C3H10T1/2 cells were plated as above and
transfected with Snai1 and Snai2 Stealth™ RNAi. After 24 h, the
cells were treated with BMP4 until postconfluence. Whole-cellTwist expression is correlated with Lox expression
during adipocyte lineage commitment
EMT is regulated by distinct transcription factors such as Snai1,
Snai2 and Twist. To identify the transcription factors that
regulate the EMT-like process during adipocyte lineage com-
mitment, Western blotting was performed on extracts from
C3H10T1/2 cells treated with or without BMP4. The expression
of Snai1, Snai2 and Twist was significantly induced by BMP4
treatment (Fig. 4A). However, the expression patterns of Twist
and Snai are quite different in Lox-silenced cells. Among these
transcription factors, only Twist was down-regulated by
knockdown of Lox, while the expression of Snai1 and Snai2
was elevated by Lox inhibition (Fig. 4B). These results suggested
that Lox is a positive regulator of Twist. Chromatin immuno-
precipitation combined with quantitative PCR (ChIP-qPCR)
confirmed that Lox was specifically recruited to the Twist1
promoter, suggesting a direct regulation of Twist by Lox
(Fig. 4C).lysates were prepared for immunoblotting. Adipocyte lineage
commitment and subsequent differentiation were assessed by
both 422/aP2 expression (B) and Oil Red O staining (C).Twist influences the BMP4-induced EMT-like
response and the adipocyte lineage commitment
To determine whether Twist is required for the EMT-like
process and has the ability to regulate adipocyte lineage
commitment, Twist1 was knocked down in BMP4-treated
cells and control cells (Figs. 5A & S2A). The basal expression
levels of EMT markers are slightly changed when Twist was
knocked down in control cells (Fig. S2A). The basal adipocyte
differentiation was prevented when Twist was knocked down
in control C3H10T1/2 cells (Figs. S2B & C). Knockdown of
Twist1 in BMP4-treated cells significantly inhibited mesenchy-
mal phenotype markers and increased epithelial phenotype
markers without affecting the expression of Lox (Fig. 5A).
Consistently, down-regulating the level of Twist inhibited the
adipocyte lineage commitment and further differentiation as
assessed by the expression of 422/aP2 (Fig. 5B) and cytoplas-
mic triglyceride accumulation (Fig. 5C). However, knockdown
of Snai1 and Snai2 (Fig. 6A) did not affect the acquisition of the
adipocyte phenotype induced by BMP4 (Figs. 6B & C). Taken
together, these findings suggest that Twist regulated by Lox
contributes to the EMT-like process during adipocyte lineage
commitment. Twist, but not Snai1 and Snai2, has the ability to
influence adipocyte lineage commitment.Discussion
Obesity results when caloric intake exceeds energy expendi-
ture, with an increase in adipocyte size or adipocyte number
(Bjorntorp, 1974; Faust et al., 1978; Johnson et al., 1971, 1978;
Yu et al., 1997). In the context of adipogenesis, development
appears to occur in two stages, i.e. commitment of MSCs to
produce preadipocytes followed by differentiation to produce
adipocytes (Otto and Lane, 2005). Although it has been esta-
blished that BMPs play a very important role in the processes by
which MSCs undergo commitment to the adipocyte lineage
(Bowers et al., 2006; Huang et al., 2009, 2011; Tang et al.,
2004), little is known about the mechanism involved.
The epithelial–mesenchymal transition is crucial in the
differentiation of multiple tissues and organs (Dedhar et al.,
2006). EMT is characterized by loss of epithelial cell polarity,
loss of cell–cell contacts, and acquisition of mesenchymal
markers and increased cell motility. Multiple signaling path-
ways such as TGF-β, Notch, Wnt and receptor tyrosine kinase-
mediated signals have all been implicated as upstream ini-
tiators of the EMT process in tumor cells and developmental
285Role of EMT-like response on adipocyte lineage commitmentcells (Heldin and Moustakas, 2007; Thiery et al., 2009; Yang
and Weinberg, 2008). Herein, we clearly revealed that BMP4
induced an EMT-like phenotype during adipocyte lineage
commitment on the basis of the following findings: (1) BMP4
treatment causes epithelial markers' repression and mesen-
chymal markers' induction; (2) BMP4 induces the expression of
the key transcription factors that regulate the EMT process;
and (3) BMP4 increases C3H10T1/2 cell motility. However, the
C3H10T1/2 cells are mesenchymal stem cells and the BMP4-
induced change in cell morphology is not as typical as a
classical EMT, so BMP4 induced an EMT-like phenotype during
adipocyte lineage commitment.
Since BMP4 is an inducer of EMT, wewonderedwhether the
observed EMT-like response is a consequence of or required for
the adipocyte lineage commitment. In order to determine
this, Cdh2 was knocked down and Cdh1 was over-expressed.
Cdh2 knockdown assays and over-expression of Cdh1 demon-
strated that the EMT-like response is necessary for adipocyte
lineage commitment.
We recently reported that Lox contributes to adipocyte
lineage commitment (Huang et al., 2009, 2011). Lox has also
been shown to be coupled to the EMT (Erler et al., 2006;
Higgins et al., 2007; Schietke et al., 2010; Sion and Figg, 2006;
Taylor et al., 2011). Interestingly, it has been shown that
chromatin reprogramming occurs in cells undergoing EMT
(McDonald et al., 2011). A mesenchymal-to-epithelial transi-
tion (MET), the reverse of EMT, is also required for theFigure 7 Model proposing a role for Lox in BMP4-induced EMT-like
increased expression of Lox and Twist thus promoting the EMT-like
involved in Lox-dependent effects on the BMP4-induced EMT duringreprogramming of fibroblasts to produce induced pluripotent
stem cells (iPSCs) (Chen et al., 2011, 2012; Li et al., 2010). Our
current studies showed that an EMT-like feature occurs during
adipocyte lineage commitment and Lox silencing induces a
MET-like process in the presence of BMP4 and antagonizes
adipocyte lineage commitment. The evidence presented here
suggests that reprogramming could also occur during the
adipocyte lineage commitment process. However, further
studies will be necessary for better understanding of re-
programming during adipocyte lineage commitment.
Both developmental and pathological EMTs are controlled
by the same core EMT regulatory factors, which include
Snai1, Snai2, Twist, and Sip1 (also known as ZEB2). Twist, a
core EMT regulatory factor, can modulate the behavior and
fate of cells in both development and cancer (Glackin et al.,
2010; Thiery et al., 2009; Weinberg et al., 2004). We found a
significant correlation between the expression of Twist and
the expression of Lox during adipocyte lineage commitment,
which suggested that Twist is regulated by Lox. Chromatin
immunoprecipitation confirmed that Lox was specifically
recruited to the Twist1 promoter, further suggesting a direct
regulation of Twist by Lox. This study reveals a functional link
between Lox and Twist which is consistent with a recently
published paper (El-Haibi et al., 2012). In addition to silencing
the expression of Cdh2 and Vim, Cdh1 and Ocln expression can
also be rescued by knocking down of Twist. We therefore
speculated that Twist contributes to the Lox-induced EMT-likeresponse during adipocyte lineage commitment. BMP4 results in
response and adipocyte lineage commitment. Twist could be
adipocyte lineage commitment.
286 H.-Y. Huang et al.response during adipocyte lineage commitment. It should be
noted that although Lox regulates Twist and Twist is involved
in the EMT-like response during adipocyte lineage commit-
ment, Lox itself is enough to induce an EMT (Schietke et al.,
2010). Snai1 and Snai2 are also induced during adipocyte
lineage commitment, however, the expression pattern of
Twist and Snai are quite different in Lox-silenced cells.
Further studies will be needed to elucidate such differences.
Overall, the present evidence indicates that Lox contributes
to the EMT-like response during adipocyte lineage commit-
ment at least in part through the activation of Twist.Conclusions
A simplified schematicmodel is proposed (see Fig. 7) illustrating
how Lox and Twist are involved in the BMP4-induced EMT-like
response and adipocyte lineage commitment. In brief, BMP4
results in increased expression of Lox (Huang et al., 2009) and
Twist thus promotes the EMT-like response and adipocyte
lineage commitment. Twist could be involved in Lox-dependent
effects on the EMT-like response during adipocyte lineage
commitment. This study presents molecular insights into cell
fate decisions in the adipocyte lineage.Acknowledgments
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